Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Macaya

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Journal of the American College of Cardiology|May 10, 2001
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trialF Kiemeneij, P W Serruys, C Macaya, et al.
The Pharmacogenomics Journal|June 26, 2002
Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex diseaseR Y L Zee, J Hoh, S Cheng, et al.
Journal of the American College of Cardiology|February 1, 1996
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study GroupC Macaya, P W Serruys, P Ruygrok, et al.
Circulation|August 1, 1996
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) StudyG B Mancini, G C Henry, C Macaya, et al.
Marine Environmental Research|June 9, 2024
Non-indigenous species and their realized niche in tidepools along the South-East Pacific coastDavid Jofré-Madariaga, Moisés A Aguilera Moya, Catharina Alves-de-Souza, et al.
Circulation|November 28, 2001
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)M A Costa, R G Carere, S V Lichtenstein, et al.
Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.
Circulation|December 13, 1997
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire TransluminaleJ M Lablanche, E P McFadden, N Meneveau, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Circulation|February 1, 1996
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot StudyP W Serruys, H Emanuelsson, W van der Giessen, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Journal of the American College of Cardiology|May 10, 2001
Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trialF Kiemeneij, P W Serruys, C Macaya, et al.
The Pharmacogenomics Journal|June 26, 2002
Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex diseaseR Y L Zee, J Hoh, S Cheng, et al.
Journal of the American College of Cardiology|February 1, 1996
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study GroupC Macaya, P W Serruys, P Ruygrok, et al.
Circulation|August 1, 1996
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) StudyG B Mancini, G C Henry, C Macaya, et al.
Marine Environmental Research|June 9, 2024
Non-indigenous species and their realized niche in tidepools along the South-East Pacific coastDavid Jofré-Madariaga, Moisés A Aguilera Moya, Catharina Alves-de-Souza, et al.
Circulation|November 28, 2001
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)M A Costa, R G Carere, S V Lichtenstein, et al.
Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.
Circulation|December 13, 1997
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire TransluminaleJ M Lablanche, E P McFadden, N Meneveau, et al.
Circulation|December 24, 1997
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996S G Ellis, H Tamai, M Nobuyoshi, et al.
Circulation|February 1, 1996
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot StudyP W Serruys, H Emanuelsson, W van der Giessen, et al.
Pageof 19